Jennifer Cote serves as Executive at HARVARD BIOSCIENCE INC, where they oversee executive responsibilities. Since joining the company, Jennifer Cote has executed 8 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Mar 6, 2024 involved selling 9,920 shares valued at $40.8K.
Jennifer Cote currently holds 168,738 shares of HARVARD BIOSCIENCE INC (HBIO), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Jennifer Cote has been a net neutral trader of HBIO stock. They have purchased $0 and sold $0 worth of shares.
Jennifer Cote's most recent insider trade was on Mar 6, 2024, when they sold 9,920 shares at $4.11 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Mar 5, 2024 | HBIO | $0 | Award | 35,800 | $N/A | Discretionary |
| Dec 29, 2023 | HBIO | $17.5K | Payment | 3,279 | $5.35 | Discretionary |
| Dec 29, 2023 | HBIO | $14.1K | Payment | 2,631 | $5.35 | Discretionary |
| Mar 6, 2023 | HBIO | $0 | Award | 26,892 | $N/A | Discretionary |
| Mar 6, 2023 | HBIO | $0 | Award | 25,862 | $N/A | Discretionary |
| Mar 6, 2023 | HBIO | $0 | Award | 29,880 | $N/A | Discretionary |